APOE and Alzheimer disease: An XGBoost model achieved an AUC of 0.60 to 0.74, depending on the various combinations of feature vectors, such as demographics, APOE genotype, cognitive and functional measures from the Trial-Ready Cohort in Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) [39].